Gold levels produced by treatment with auranofin and sodium aurothiomalate.
Sixty-three patients with rheumatoid arthritis were randomly divided into 3 groups, and treated with either sodium aurothiomalate (Myocrisin), auranofin, or placebo. Gold levels in whole blood, plasma, and haemolysate were measured serially along with clinical and laboratory parameters of efficacy....
Tallennettuna:
| Julkaisussa: | Ann Rheum Dis |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMJ Publishing Group
1983
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1001298/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6414387/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.42.5.566 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
